Compare J M Smucker Co (SJM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs Tenet Healthcare Corporation — how do they compare? J M Smucker Co trades at $120.56 (market cap $12.76B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and J M Smucker Co pays a 3.75% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold J M Smucker Co for 74 Days and Tenet Healthcare Corporation for 15 Days on average.
| SJM | THC | |
|---|---|---|
Market Cap | $12.76B | $20.98B |
Volume | 1,300,545 | 428,008 |
Sector | Consumer Staples | Health |
52-Week High | $132.34 | $280.77 |
52-Week Low | $89.53 | $161.37 |
Typical Hold Time | 74 Days | 15 Days |
Enterprise Value | $19.61B | $32.06B |
Dividend Yield | 3.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SJM trades at $115.93, down 0.74% on the day, with a bearish technical signal. The company reported a net loss of $1.23 billion in 2025 despite revenue growth to $8.73 billion, though recent quarters have beaten EPS estimates. Analyst consensus is a Buy with a $137.29 price target, and a dividend of $1.12 is scheduled for September 2026.
The outlook is mixed: strong recent earnings beats and positive analyst sentiment suggest upside, but high P/E of 54.17 and volatile profitability pose risks. Key opportunities include raised FY2027 guidance and brand strength, while risks involve margin pressure and high debt levels impacting shareholder value.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
